Winnie Lam

​Dr Lam has post-graduate medical training in both Diagnostic Radiology and Nuclear Medicine, became a Fellow of the Royal College of Radiologists (UK) in 2007 and Fellow of the Academy of Medicine in Nuclear Medicine in 2010. She has also done clinical training in the Department of Nuclear Medicine at University Hospital Zurich.

Dr Lam is currently Vice-Chair of the Chapter of Nuclear Medicine in the College of Radiologists, Singapore.

Dr Lam is Program Director of the Nuclear Medicine Residency Program as well as Clinical Physician Faculty Member of the Diagnostic Radiology and Endocrinology Residency Programs. She is also an Adjunct Assistant Professor at the Duke-NUS Medical School, a Clinical Senior Lecturer with the National University of Singapore Yong Loo Lin School of Medicine and an External Lecturer in Nanyang Polytechnic.

Her clinical interests include oncologic and non-oncologic applications of PET/CT, SPECT/CT and radionuclide therapy.

Education

• Fellow of the Academy of Medicine, Singapore in Nuclear Medicine, 2010
• Fellow of the Royal College of Radiologists (UK), 2007

Professional Appointments and Committee Memberships

• Adjunct Assistant Professor,Duke-NUS Medical School
• Clinical Senior Lecturer, NUS Yong Yoo Lin School of Medicine
• Vice-Chair, Chapter of Nuclear Medicine, College of Radiologists, Singapore 2013-present
• Department IT Team Advisor, Department of Nuclear Medicine and Molecular Imaging, 2017-present
• Member, RISPACS/IMS Steering Committee, SingHealth, 2016-present
• Team Leader, Quality Improvement Team, Department of Nuclear Medicine and Molecular Imaging, 2016-present
• Team leader, Radioiodine Therapy Coordinated Clinical Pathways, Singapore General Hospital, 2009-present
• Member, MOH Advisory Committee on Nuclear Medicine, 2015-17
• Member, Working group on feasibility of and issues related to dual-accreditation between Nuclear Medicine and Diagnostic Radiology, College of Radiologists, Singapore, 2010
• Honorary Secretary, Singapore Radiological Society, 2009-10

Awards

• Outstanding Faculty Award, Residency in SingHealth Excels (RiSE) Award, 2013-14
• 10-Year Long Service Award, Singapore General Hospital
• Silver Award, SGH Team Excellence IQC Assessment by Singapore Productivity Association 2016

Research Interests

• Nuclear medicine
• Molecular Imaging

Publications

Publications

• Letter to the Editor: RE: “Is 16 Months of Specialized Nuclear Medicine Training Enough for Best Patient Care?”.
• Lam WW
• Journal of Nuclear Medicine. 2017. doi: 10.2967/jnumed.117.203240
• The Utility of FDG PET/CT in IgG4-Related Disease with a Focus on Coronary Artery Involvement.
• Huang HL, Fong W, Peh WM, Niraj KA, Lam WW.
• Nuclear Medicine and Molecular Imaging. 2017. doi: 10.1007/s13139-017-0494-5
• Subacute Thyroiditis – An Often Overlooked Sonographic Diagnosis: Report of 3 Cases.
• Lee MY, Lam WW, Wong WY.
• Journal of Ultrasound in Medicine. May 2016; 35(5):1095-1100
• Unusual mediastinal lymph node uptake and peritoneopleural fistula demonstrated on Technetium-99m macro-aggregated human serum albumin (Tc-99m MAA) peritoneal scintigraphy in a patient with portal hypertension.
• Tan CJ, Thang SP, Lam WW.
• Medical Journal of Malaysia. Apr 2016; 71(2):69-71
• Gender, race and age at diagnosis as risk factors for metastasis or recurrence among 1,657 thyroid cancer patients treated with radioiodine across 40 years in Singapore.
• Kao YH, Gan HK, Zaheer S, Lam WWC, Loke KSH, Wong WY, Ng DCE, Goh ASW.
• Oncology Research and Treatment. Dec 2015; 38(12): 679-682
• Cardiac structural abnormalities associated with IgG4-related coronary periarteritis and inflammation revealed by multimodality imaging.
• Tong AK, Tan SY, Go YY, Lam WW.
• Canadian Journal of Cardiology. Aug 2014; 30(8): 956.e15-17
• Pancreatic metastasis detected by F-18 FDG PET/CT in a patient with breast cancer.
• Lam WW, Loke KS, Loi HY, Padhy AK.
• Clinical Nuclear Medicine. Jun 2011; 36(6): 479-480
• Promising role of [18F] fluorocholine PET/CT vs [18F] fluorodeoxyglucose PET/CT in primary brain tumors - early experience.
• Lam WW, Ng DC, Wong WY, Ong SC, Yu SW, See SJ.
• Clinical Neurology and Neurosurgery. Feb 2011; 113(2): 156-161
• Biliary non-Hodgkin lymphoma detected by F-18 FDG PET/CT.
• Lam WW, Osmany S.
• Clinical Nuclear Medicine. Nov 2009; 34(11): 791-792
• Visualization of mesenteric arterial collaterals after occlusion of abdominal aorta detected on Tc-99m-labeled red blood cell imaging.
• Lam WW, Wong WY, Tay KH.
• Clinical Nuclear Medicine. Jan 2009; 34(1): 35-37
• Role of F-18 FDG PET/CT in disseminated tuberculosis.
• Lam WWC, Padhy AK, Magsombol B, Chan NHK, Tan TT, Ng DCE, Wong JSL, Goh ASW, Lim ST.
• World Journal of Nuclear Medicine. Jul 2008; 7(3): 177-180
• Colour Doppler ultrasonography replacing surgical exploration for acute scrotum: myth or reality?
• Lam WW, Yap TL, Jacobsen AS, Teo HJ.
• Pediatric Radiology. Jun 2005; 35(6): 597-600

Research Trials

Research

• 2017-25 A randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of CNP520 in participants at risk for the onset of clinical symptoms of Alzheimer’s Disease (AD) (as Co-Investigator) – ongoing
• Principal Investigator: Nagaendran Kandiah, Dept of Neurology (TTSH Campus), NNI (Novartis CCNP520A2202J)
• 2017-18 Systemic inflammatory response, nutritional status & [18F]FDG-PET imaging as potential prognostic biomarkers in esophageal cancer treated with chemoradiation (as Co-Investigator) – ongoing
• Principal Investigator: Connie Yip, Div of Radiation Oncology, NCCS (CIRB Ref. No. 2016/3103)
• 2015-16 Pilot study to assess the utility of Gallium-68 labelled prostate specific membrane antigen (PSMA) ligand PET/CT imaging in detecting disease recurrence in prostate cancer patients with biochemical relapse (as Principal Investigator)